Five-Year Operating Licence Validity and the Sixty Working Day Renewal Window
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
A Panamanian medical device operating licence is valid for five years, and the renewal application must be filed sixty working days before the expiry date (sesenta días hábiles antes de su fecha de expiración), under Article 13 of Decreto Ejecutivo N° 490. The deadline is not a target to be worked towards but a statutory precondition, and the sanction for missing it is unusually broad: once a licence is expired, suspended or cancelled, the supplier may not market any device or related product anywhere in Panama, as stated in the final paragraph of Article 19. This is among the most consequential deadline provisions in the Panamanian compliance chain, because it operates at the level of the legal person rather than the product, and it does not depend on the status of any individual sanitary registration.
Three structural features shape how the deadline should be managed. The first is the unit of measurement: Panama counts in working days, not calendar days, so the nominal sixty-day window is closer to three months in real time. The second is the relationship between the renewal window and the statutory processing period: Article 20 allows up to forty-five working days for a decision, plus a further forty-five working days where the authority requests corrections, which can exceed the window in which the renewal may be filed. The third is that the regulator has previously used resolutions to move validity dates, which means the published rule and the operative rule are not always identical. Each of these points is examined below.
2. Legal basis
Article 13 fixes both the term and the filing window in a single sentence. Article 19, final paragraph, sets out the consequence of lapse. Article 20 governs the processing clock and the treatment of incomplete files. Resolución N° 091 of 11 October 2021 repealed Resolución No. 019 of 6 April 2020, a pandemic-era measure that had temporarily extended the validity of operating licences issued by DNDM, and Resolución N° 852 of 30 October 2019 remains the procedural manual covering issuance, renewal, update, correction, suspension and cancellation.
| Decreto Ejecutivo N° 490 (4 October 2019) | Article 13 | La licencia de operación tendrá una vigencia de cinco (5) años y su renovación deberá tramitarse sesenta días hábiles antes de su fecha de expiración. |
| Same | Article 19, final paragraph | Si la Licencia de Operación se encuentra vencida, suspendida o cancelada, el proveedor no podrá comercializar ningún Dispositivo Médico o producto afín en el territorio nacional. |
| Same | Article 20 | Applications and their updates, renewals and corrections must be decided within no more than 45 working days of proof that requirements are met; where corrections are required a further 45 working days is granted; failure to comply is treated as withdrawal |
| Same | Article 12 | The licence is issued by DNDM and certifies that premises and processes meet quality and safety standards |
| Resolución N° 091 (11 October 2021) | In full | Repeals Resolución No. 019 of 6 April 2020, which had temporarily extended the validity of operating licences issued by DNDM |
| Resolución N° 852 (30 October 2019) | In full | Procedural manual for the issuance, renewal, update, correction, suspension and cancellation of operating licences |
3. Expert insights
Insight one: sixty working days is not sixty calendar days, and the conversion gives a window of nearly three months. In Panama, días hábiles means business days, excluding weekends and public holidays. On a five-day week, sixty working days is roughly twelve weeks, or about eighty-four calendar days. Once public holidays are added the window stretches further. Reading the figure as calendar days produces an under-estimate of the lead time available; reading it as sixty calendar days and working backwards produces the opposite error, a filing date that falls after the statutory opening. The reliable method is to count backwards in working days from the expiry date on a published holiday calendar, then add a further buffer.
Insight two: the renewal window and the approval period must be added together, and the arithmetic does not favour the applicant. Article 20 gives DNDM forty-five working days for an application including a renewal, and a further forty-five working days where corrections are requested. In the worst case, therefore, completion takes ninety working days, while the renewal may only be filed sixty working days before expiry. Since sixty is less than ninety, a file that enters the correction channel can still be open when the existing licence lapses, which triggers the marketing prohibition in the final paragraph of Article 19. This is the single time conflict in Panamanian licence management that most deserves a standing contingency plan, and the only reliable mitigation is to file a complete dossier at the first possible date rather than at the last permitted one.
Insight three: the consequence of the final paragraph of Article 19 is a blanket prohibition, not a product-specific one. The official wording is no podrá comercializar ningún Dispositivo Médico o producto afín: no device or related product may be marketed, not merely the product connected with whatever caused the lapse. Because the licence is a company-level permission, its loss simultaneously removes the marketing qualification of every product held by that entity. For a distributor carrying multiple lines, this is a systemic exposure rather than an isolated one, and it explains why licence status belongs in business continuity planning and not only in regulatory administration.
Insight four: the existence of Resolución N° 091 de 2021 shows that Panama has used resolutions to extend validity temporarily. That instrument repealed Resolución No. 019 de 2020, which had extended the validity of operating licences issued by DNDM for a defined period. The lesson is not that extensions are available when needed, but that the operative validity date can be moved by an instrument below the level of the decree. A compliance calendar built only from the law and the decree will miss measures of this kind, so resolution-level monitoring is part of the task rather than an optional extra.
4. Practical recommendations
- Maintain a licence expiry register that sets the first alert at the expiry date minus sixty working days, and an earlier preparation alert a further thirty calendar days before that.
- Assemble renewal documentation in a single complete submission, so that the file does not enter the forty-five working day correction channel under Article 20.
- For entities holding multiple product lines, treat licence lapse as a systemic risk item and include it in the business continuity plan alongside supply and quality risks.
- Monitor DNDM for any resolution temporarily extending validity, using Resolución 091 and Resolución 019 as the precedent for what such a measure looks like.
- Review licence status, whether valid, suspended or cancelled, as part of a monthly compliance check rather than an annual one.
- Record the working-day calculation and the holiday calendar used, so that the filing date can be defended if the window is later questioned.
5. Verification checklist
- □ Five-year validity recorded and diarised (Article 13)
- □ Renewal alert set by counting back sixty working days, not calendar days
- □ Approval period under Article 20 modelled as forty-five plus forty-five working days
- □ Licence status confirmed as neither expired, suspended nor cancelled (Article 19, final paragraph)
- □ Any current resolution temporarily extending validity searched and reviewed
- □ Licence status included in the monthly compliance check
- □ Renewal dossier complete before the window opens, to avoid the correction channel
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us